Tacconelli, E., Göpel, S., Gladstone, B. P., Eisenbeis, S., Hölzl, F., Buhl, M., Górska, A., Cattaneo, C., Mischnik, A., Rieg, S., Rohde, A. M., Kohlmorgen, B., Falgenhauer, J., Trauth, J., Käding, N., Kramme, E., Biehl, L. M., Walker, S. V., Peter, S., Gastmeier, P., Chakraborty, T., Vehreschild, M. J., Seifert, H., Rupp, J., Kern, W. V., , , Lemke, E., Thoma, N., Wolke, S., Imirzalioglu, C., Herold, S., Tewes, N., Fritzenwanker, M., Vehreschild, J. J., Classen, A. Y., Tobys, D., Higgins, P., Blum, Y., Kleipaß, M., Höltig, L., Nagel, K., Schmauder, K., Künstle, L., Stoll, E., Dinkelacker, A. G., Peyerl-Hoffmann, G., Häcker, G., Spitznagel, H., & Olawumi-Hurter, S. C. (2022). development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study. Lancet infectious diseases, 22(5), 731–741. http://access.bl.uk/ark:/81055/vdc_100153781483.0x00000d